Trial intelligence / Profile preview

Behavioral Consequences of Blunting Fear With Acetaminophen

NCT05396677Completed

Sponsor
University of Guelph
Start
Mar 2022
Primary completion
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in phobic disorder comparing Acetaminophen Condition with Placebo Condition (2 arms). Primary endpoints: Walking speed on plank in virtual reality, Distance walked on plank and 5 more. Started Mar 2022; status: completed.

02

Drugs

acetaminophen
03

Conditions

phobic disorder

Beyond the preview

Go deeper on NCT05396677.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05396677.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call